Workflow
Danaher Q3 Earnings Beat Estimates, Life Sciences Sales Up Y/Y
丹纳赫丹纳赫(US:DHR) ZACKS·2025-10-22 01:41

Key Takeaways Danaher's Q3 adjusted EPS rose 10.5% year over year to 1.89,toppingconsensusestimates.Netsalesgrew4.51.89, topping consensus estimates.Net sales grew 4.5% to 6.05 billion, with all segments contributing to year-over-year gains.Operating profit jumped 20.5%, expanding margins to 19.1% from 16.5% in the prior year.Danaher Corporation’s (DHR) third-quarter 2025 adjusted earnings of 1.89persharebeattheZacksConsensusEstimateof1.89 per share beat the Zacks Consensus Estimate of 1.71. The bottom line increased 10.5% year over year.Danaher reported net sales of $6.05 billion, which be ...